Please wait





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person:  The shares of the Common Stock reported herein consist of 21,738 shares of Common Stock and warrants to purchase 1,304,348 shares of Common Stock, subject to a 9.99% beneficial ownership limitation, held by the Reporting Persons as of the date of this report. Percentage calculated based on 1,461,449 shares of Common Stock outstanding as of May 13, 2026, as reported in the Form 10-Q filed by the Issuer for the quarter ended March 31, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person:  The shares of the Common Stock reported herein consist of 21,738 shares of Common Stock and warrants to purchase 1,304,348 shares of Common Stock, subject to a 9.99% beneficial ownership limitation, held by the Reporting Persons as of the date of this report. Percentage calculated based on 1,461,449 shares of Common Stock outstanding as of May 13, 2026, as reported in the Form 10-Q filed by the Issuer for the quarter ended March 31, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person:  The shares of the Common Stock reported herein consist of 21,738 shares of Common Stock and warrants to purchase 1,304,348 shares of Common Stock, subject to a 9.99% beneficial ownership limitation, held by the Reporting Persons as of the date of this report. Percentage calculated based on 1,461,449 shares of Common Stock outstanding as of May 13, 2026, as reported in the Form 10-Q filed by the Issuer for the quarter ended March 31, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person:  The shares of the Common Stock reported herein consist of 21,738 shares of Common Stock and warrants to purchase 1,304,348 shares of Common Stock, subject to a 9.99% beneficial ownership limitation, held by the Reporting Persons as of the date of this report. Percentage calculated based on 1,461,449 shares of Common Stock outstanding as of May 13, 2026, as reported in the Form 10-Q filed by the Issuer for the quarter ended March 31, 2026.


SCHEDULE 13G



 
Stonepine Capital Management, LLC
 
Signature:/s/ Jon M. Plexico
Name/Title:Managing Member
Date:05/15/2026
 
Stonepine Capital, L.P.
 
Signature:/s/ Jon M. Plexico
Name/Title:Managing Member of the General Partner, Stonepine GP, LLC
Date:05/15/2026
 
Stonepine GP, LLC
 
Signature:/s/ Jon M. Plexico
Name/Title:Managing Member
Date:05/15/2026
 
Jon M. Plexico
 
Signature:/s/ Jon M. Plexico
Name/Title:Reporting person
Date:05/15/2026
Exhibit Information

EXHIBIT 99 - AGREEMENT REGARDING JOINT FILING OF STATEMENT ON SCHEDULE 13D OR 13G